Clin2
NCT06569212Possibly a fitRecruiting

Beta-blocker to reduce heart damage after brain bleed

Non-Traumatic Subarachnoid Hemorrhage

Treatments studied

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests whether a common beta-blocker (metoprolol) can protect the heart from injury and reduce inflammation after a bleed in the brain (subarachnoid hemorrhage). It may help patients recover better after this type of stroke.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have had a confirmed, non-traumatic brain bleed (subarachnoid hemorrhage).
  • You are over 18 years old.
  • You are not currently pregnant.
  • Your vital signs (blood pressure and heart rate) are stable enough to safely take a beta-blocker.
  • You do not have severe heart failure.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07243704Recruiting· Phase 3
Antiplatelet medicine to prevent heart events after brain bleed

This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.

Guntur, Andhra Pradesh
NCT06870370Not yet recruiting· Phase 3
Beta-blocker treatment for severe traumatic brain injury

This trial tests whether a heart medication called a beta-blocker can help people who have had a severe traumatic brain injury. By reducing stress on the body, it may support recovery.

Tanta
NCT06836856Recruiting· Phase 1/Phase 2
Beta blockers after traumatic brain injury: a study

This trial tests whether giving a beta blocker drug after a moderate or severe traumatic brain injury can improve recovery. It is for patients who have a brain injury but only minor or no other injuries.

Zagazig
NCT06967194Recruiting
Early beta blocker use after heart attack with fast heart rate or low blood pressure

This trial is testing whether giving a beta-blocker medication (metoprolol) early after a heart attack can help people who have a fast heart rate or low blood pressure but no signs of organ failure. The goal is to see if this treatment improves recovery.

Tel Aviv
NCT06249802Not yet recruiting· Phase 4
Testing a beta-blocker for unruptured brain aneurysm

This trial tests whether a beta-blocker medication (a type of drug often used for heart conditions) can help prevent unruptured brain aneurysms from growing or bleeding. It is for people whose aneurysm could not be treated with surgery or catheter-based procedures, offering a potential medical alternative.

Krakow, Lesser Poland Voivodeship
NCT06760078Not yet recruiting· Phase 4
Early drug and blood pressure control for brain bleeding

This trial tests whether giving a drug called tranexamic acid (helps stop bleeding) along with very careful blood pressure lowering can reduce bleeding growth and improve recovery after a brain bleed. It is for people who arrive at the hospital very quickly (within 2 hours) after symptoms start.

Beijing, Beijing Municipality

Hear when a new Non-Traumatic Subarachnoid Hemorrhage trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.